PLAU and breast carcinoma: As demonstrated in Figs. 11 and 12, treatment of MBA-MD-231 human breast cancer cells with metformin inhibited uPA expression on mRNA Fig. 11 and protein Fig. 12 levels as compared to vehicle-treated cells in a dose-dependent manner.